Albany Molecular Research, Inc. (NASDAQ:AMRI)
CAPS Rating:
The Company is a global chemistry-based drug discovery and development company focused on identifying and developing novel biologically active small molecules with applications in the drug market.
RSS Headlines
Fool UK
Recs
There are currently 4500 AMRI shares in my "fund" with break-even of around 3.75 USD.
http://caps.fool.com/Blogs/fund-trades/678775.
now 5200 shares in the fund with break-even of around 8.54 USD.
http://caps.fool.com/Blogs/fund-trades/705717.
http://twitter.com/portefeuillefun.